Ad
BCRX Quote Trading Chart BioCryst Pharmaceuticals Inc.
home / stock / bcrx / bcrx quote
$14.64 Last:
32.85% Change Percent:
$14.6 Open:
$11.02 Previous Close:
$14.86 High:
$14.44 Low:
2,788,600 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BCRX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 14.6 | 11.02 | 14.86 | 14.44 | 2,788,600 |
| 2022-08-11 | 14.79 | 11.02 | 14.97 | 14.2238 | 3,294,804 |
| 2022-08-10 | 14.69 | 11.02 | 14.89 | 14.525 | 2,004,030 |
| 2022-08-09 | 14.1 | 11.02 | 14.71 | 13.79 | 3,504,571 |
| 2022-08-08 | 13.97 | 11.02 | 15.43 | 13.9 | 4,674,419 |
| 2022-08-05 | 12.93 | 11.02 | 14.32 | 12.88 | 6,070,008 |
| 2022-08-04 | 12.71 | 11.02 | 14.19 | 12.35 | 11,711,919 |
| 2022-08-03 | 11.29 | 11.02 | 11.7492 | 11.02 | 3,173,509 |
| 2022-08-02 | 10.78 | 11.02 | 11.145 | 10.7 | 1,486,136 |
| 2022-08-01 | 10.91 | 11.02 | 11.2 | 10.775 | 1,812,136 |
| 2022-07-29 | 10.93 | 11.02 | 11.07 | 10.65 | 1,812,397 |
| 2022-07-28 | 11.02 | 11.02 | 11.09 | 10.64 | 1,344,198 |
| 2022-07-26 | 10.76 | 10.76 | 11.04 | 10.56 | 855,371 |
| 2022-07-25 | 11.2 | 10.9 | 11.2 | 10.82 | 1,930,838 |
| 2022-07-19 | 11.54 | 11.83 | 11.935 | 11.54 | 2,058,678 |
| 2022-07-18 | 11.83 | 11.36 | 12.02 | 11.28 | 2,260,997 |
| 2022-07-15 | 11.66 | 11.65 | 11.68 | 11.165 | 3,435,429 |
| 2022-07-14 | 11.88 | 11.49 | 11.99 | 11.42 | 2,944,779 |
| 2022-07-13 | 11.06 | 11.97 | 12.03 | 10.96 | 2,943,497 |
| 2022-07-12 | 11.09 | 11.24 | 11.44 | 10.865 | 2,994,906 |
BioCryst Pharmaceuticals Inc. Company Name:
BCRX Stock Symbol:
NASDAQ Market:
BioCryst Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX) Q2 2022 Earnings Call Aug 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript ...
-
Shares of the rare disease specialist BioCryst Pharmaceuticals (NASDAQ: BCRX) were up by a noteworthy 20% on heavy volume at 9:38 a.m. ET Thursday morning. Although the biotech reported encouraging 2022 second-quarter results prior to today's opening bell, the real needle mover ...
-
—Q2 2022 ORLADEYO net revenue of $65.2 million— —FY 2022 ORLADEYO net revenue expected to be between $255 million and $265 million— RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:...